To determine the effects of Oct1 in T cells on the pathogenesis of a neuroautoimmune disease, we used Oct1 T cell conditional mice (CD4-Cre;Oct1fl/fl [4] and control mice (Oct1fl/fl) in conjunction with a MOG-EAE model of MS. This evidence concerns the gene CD4 and myeloid sarcoma.